Axq Capital, LP Spring Works Therapeutics, Inc. Put Options Transaction History
Axq Capital, LP
- $222 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SWTX
# of Institutions
235Shares Held
67.2MCall Options Held
260KPut Options Held
316K-
Vanguard Group Inc Valley Forge, PA7.16MShares$403 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$316 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.46MShares$195 Million5.51% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.27MShares$184 Million0.01% of portfolio
-
State Street Corp Boston, MA3MShares$169 Million0.0% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $3.51B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...